Anti-DNM2 antibodies are used in the immunodetection of the protein dynamin 2. In humans, the canonical protein has a reported length of 870 amino acid residues and a mass of 98.1 kDa. Its subcellular localization is in the membrane, cytoplasmic vesicles, and cytoplasm. Up to 5 different isoforms have been reported for this protein. It is ubiquitously expressed across many tissue types. A member of the Dynamin/Fzo/YdjA protein family, DNM2 is known to be involved with endocytosis. Post-translational modifications have been described, including phosphorylation. The DNM2 gene has been associated with the disease, Myopathy. Synonyms for this target antigen include CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII, LCCS5, dynamin II, and CMT2M. DNM2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chimpanzee species. Over 70 citations in the literature describe the use of DNM2 antibodies in research. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.